Clinical Trials Logo
  1. Home
  2. Lupus
  3. NCT00053560

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Lupus Clinical Trial

Official title:
A Randomized, Double-Blind, Multi-Center, Placebo- Controlled Study to Assess Prevention of Bone Loss by Treatment With GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

Clinical Trial Summary

The purpose of this clinical trial is to study the effects of GL701 on bone mineral density in women with active systemic lupus erythematosus (SLE) who are also receiving treatment with glucocorticoids (e.g., prednisone).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00053560
Study type Interventional
Source Genelabs Technologies
Contact
Status Active, not recruiting
Phase Phase 3
Start date December 2002
Completion date August 2004
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06013995 - A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus Phase 1
Recruiting NCT03952624 - Patient-Centered Assessment of Symptoms and Outcomes
Terminated NCT01389895 - Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus Phase 1
Completed NCT00710021 - Vitamin D3 in Systemic Lupus Erythematosus Phase 2
Completed NCT02265744 - Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus Phase 2
Recruiting NCT06445127 - Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging) N/A
Completed NCT00581763 - Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies N/A
Recruiting NCT01172002 - Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis N/A
Completed NCT00299819 - Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) Phase 1
Completed NCT00054938 - Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) Phase 2
Terminated NCT03953690 - Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
Recruiting NCT05715463 - Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity N/A
Enrolling by invitation NCT05321108 - Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus N/A
Completed NCT00482989 - A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus Phase 1
Completed NCT00657189 - A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus Phase 2
Recruiting NCT04334031 - Deployment o the Multidisciplinary Prospective Cohort Imminent N/A
Completed NCT03402087 - A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients Phase 1
Completed NCT02857452 - Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire N/A
Terminated NCT03186794 - Aerobic Exercise in Women With Systemic Lupus Erythematosus N/A
Recruiting NCT05922722 - Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus